[
  {
    "slug": "hyhel10",
    "title": "HyHEL-10: The Classic Antibody-Antigen Complex",
    "category": "reference-binder",
    "relatedChallenges": [
      "lysozyme"
    ],
    "contentFile": "help-articles/hyhel10.md"
  },
  {
    "slug": "d3l11",
    "title": "D3-L11: A High-Affinity Lysozyme Nanobody",
    "category": "reference-binder",
    "relatedChallenges": [
      "lysozyme"
    ],
    "contentFile": "help-articles/d3l11.md"
  },
  {
    "slug": "cabhul5",
    "title": "cAbHuL5: The Amyloid-Blocking Nanobody",
    "category": "reference-binder",
    "relatedChallenges": [
      "lysozyme"
    ],
    "contentFile": "help-articles/cabhul5.md"
  },
  {
    "slug": "gfp-enhancer",
    "title": "GFP Enhancer: The Brightness-Boosting Nanobody",
    "category": "reference-binder",
    "relatedChallenges": [
      "gfp"
    ],
    "contentFile": "help-articles/gfp-enhancer.md"
  },
  {
    "slug": "lag16",
    "title": "LaG16: Ultra-High Affinity GFP Binder",
    "category": "reference-binder",
    "relatedChallenges": [
      "gfp"
    ],
    "contentFile": "help-articles/lag16.md"
  },
  {
    "slug": "gfp-minimizer",
    "title": "GFP Minimizer: The Dimming Nanobody",
    "category": "reference-binder",
    "relatedChallenges": [
      "gfp"
    ],
    "contentFile": "help-articles/gfp-minimizer.md"
  },
  {
    "slug": "bamlanivimab",
    "title": "Bamlanivimab: First COVID-19 Antibody Therapy",
    "category": "reference-binder",
    "relatedChallenges": [
      "spike-rbd"
    ],
    "contentFile": "help-articles/bamlanivimab.md"
  },
  {
    "slug": "s309",
    "title": "S309: The Broadly Neutralizing Antibody",
    "category": "reference-binder",
    "relatedChallenges": [
      "spike-rbd"
    ],
    "contentFile": "help-articles/s309.md"
  },
  {
    "slug": "ace2-decoy",
    "title": "ACE2: The Natural Receptor as Decoy",
    "category": "reference-binder",
    "relatedChallenges": [
      "spike-rbd"
    ],
    "contentFile": "help-articles/ace2-decoy.md"
  },
  {
    "slug": "adalimumab",
    "title": "Adalimumab: The World's Best-Selling Drug",
    "category": "reference-binder",
    "relatedChallenges": [
      "tnf-alpha"
    ],
    "contentFile": "help-articles/adalimumab.md"
  },
  {
    "slug": "infliximab",
    "title": "Infliximab: The First TNF Blocker",
    "category": "reference-binder",
    "relatedChallenges": [
      "tnf-alpha"
    ],
    "contentFile": "help-articles/infliximab.md"
  },
  {
    "slug": "certolizumab",
    "title": "Certolizumab: The Fab-Only Approach",
    "category": "reference-binder",
    "relatedChallenges": [
      "tnf-alpha"
    ],
    "contentFile": "help-articles/certolizumab.md"
  },
  {
    "slug": "s2b-insulin",
    "title": "S2B: The AI-Designed Insulin Receptor Binder",
    "category": "reference-binder",
    "relatedChallenges": [
      "insulin"
    ],
    "contentFile": "help-articles/s2b-insulin.md"
  },
  {
    "slug": "atezolizumab",
    "title": "Atezolizumab: Cancer Immunotherapy Pioneer",
    "category": "reference-binder",
    "relatedChallenges": [
      "pd-l1"
    ],
    "contentFile": "help-articles/atezolizumab.md"
  },
  {
    "slug": "trastuzumab",
    "title": "Trastuzumab: The Breast Cancer Revolution",
    "category": "reference-binder",
    "relatedChallenges": [
      "her2"
    ],
    "contentFile": "help-articles/trastuzumab.md"
  },
  {
    "slug": "rituximab",
    "title": "Rituximab: The First Cancer Antibody",
    "category": "reference-binder",
    "relatedChallenges": [
      "cd20"
    ],
    "contentFile": "help-articles/rituximab.md"
  },
  {
    "slug": "bevacizumab",
    "title": "Bevacizumab: Starving Tumors of Blood",
    "category": "reference-binder",
    "relatedChallenges": [
      "vegf-a"
    ],
    "contentFile": "help-articles/bevacizumab.md"
  },
  {
    "slug": "evolocumab",
    "title": "Evolocumab: Genetic Discovery to Drug",
    "category": "reference-binder",
    "relatedChallenges": [
      "pcsk9"
    ],
    "contentFile": "help-articles/evolocumab.md"
  }
]